Extended-release oral capsule of carbidopa–levodopa in Parkinson disease

Motor fluctuations complicate the treatment of patients with Parkinson’s disease receiving levodopa. Extended-release carbidopa–levodopa has a pharmacokinetic profile that provides a more continuous levodopa serum concentration. Patients taking this formulation can expect longer duration of action a...

Descripción completa

Detalles Bibliográficos
Autores principales: Margolesky, Jason, Singer, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784558/
https://www.ncbi.nlm.nih.gov/pubmed/29399046
http://dx.doi.org/10.1177/1756285617737728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5784558/
https://www.ncbi.nlm.nih.gov/pubmed/29399046
http://dx.doi.org/10.1177/1756285617737728

Ejemplares similares